Maneesh most recently served as Chief Operating Officer and Director at Exact Sciences until 2018. Exact Sciences’ focus is the early detection and prevention of cancer. Exact’s lead product, Cologuard®, was developed in collaboration with the Mayo Clinic and is now widely available in the US as a frontline screening method for colorectal cancer, reimbursed by both Medicare and all major insurers. Previously, Maneesh worked for Third Wave Technologies, Inc., a molecular diagnostics company, from 2003 until its acquisition by Hologic, Inc. in July 2008. Third Wave Technologies developed an HPV product for cervical cancer screening. During his time at Third Wave, Maneesh was responsible for business strategy and commercial operations before being promoted to chief financial officer in January 2006. Maneesh earned a BA in economics from the University of Chicago and an MBA from the Kellogg School of Management at Northwestern University.